某院209株肺炎克雷伯菌临床分布和耐药性分析

doi:10.3969/j.issn.1000-8535.2021.04.019

摘要/Abstract

摘要： 目的分析濮阳市人民医院肺炎克雷伯菌(Klebsiella pneumoniae,K. pneumoniae, KPN) 的临床分布、流行病学特点及耐药情况,以促进临床合理用药。方法回顾性分析濮阳市人民医院2020年1—3月临床送检标本中分离出的209株肺炎克雷伯菌的分布及耐药情况。结果临床标本中共分离出肺炎克雷伯菌209株,在肠杆菌科细菌中占比为68.30%;标本来源以痰液、血液和尿液为主,分别占75.11%、9.09%、5.74%;分离菌株数量较多的科室为ICU、神经外科一病区、EICU病区和胸外科病区,分别占比47.37%、 17.7%、3.35%和3.35%。产超广谱β-内酰胺酶(ESBLs)菌株检出率为11.48%,耐碳青霉烯肺炎克雷伯菌(CRKP)检出率为58.37%。不同来源KPN的耐药性具有显著差异, 综合ICU KPN的耐药率高于其他病区。结论濮阳市人民医院临床分离KPN对常用抗菌药物有一定的耐药性,尤其以综合ICU分离菌株耐药严重,应加强监测KPN耐药情况,有针对性的选择抗菌药物,并增强院感防控,以减轻KPN的耐药情况。

关键词: 肺炎克雷伯菌, 临床分布, 抗菌药物, 耐药性

Abstract: Objective To analyze the characteristic of clinical distribution, epidemiological and drug resistance of Klebsiella pneumoniae (KPN) in the People's Hospital of Puyang City,and to provide evidence for rational use of antimicrobial drugs in clinical treatment. Methods A retrospectively analysis was conducted on 209 strains of KPN isolated from the clinical specimens in the People's Hospital of Puyang City from January 2020 to March 2020. Results A total of 209 strains of KPN were isolated from clinical specimens, accounting for 68.30% of enterobacteriaceae bacteria; the sources of specimen were mainly from sputum, blood and urine, accounting for 75.11%, 9.09% and 5.74% respectively; the departments with more isolated strains were ICU department, neurosurgery first department, EICU department, and thoracic surgery department, accounting for 47.37%, 17.7%, 3.35% and 3.35% respectively. Besides, the detection rate of extended spectrum β-lactamase(ESBLs) strains was 11.48%,and the detection rate of carbapenems-resistant klebsiella pneumoniae (CRKP) strains was 58.37%. The results showed that the drug resistance of KPN from different sources was with a significantly difference, and the drug resistance rate of KPN in comprehensive ICU was significantly higher than that of other departments. Conclusion The resistance of KPN isolated from the People's Hospital of Puyang City to common antibiotics is not optimistic. In particularly, the drug resistance of KPN isolated strains from the comprehensive ICU is more serious. Hence, the monitoring of KPN resistance should be strengthened and the effective prevention and control measures of hospital infection should be adopted. Furthermore, antibacterial drugs should be used rationally to reduce the generation of drug-resistant bacteria.

Key words: Klebsiella pneumoniae, Clinical distribution, Antibiotics, Drug resistance

董云玲, 张风林, 李永兵, 郭瑞娟. 某院209株肺炎克雷伯菌临床分布和耐药性分析[J]. 广州医药, 2021, 52(4): 86-91.

DONG Yunling, ZHANG Fenglin, LI Yongbing, GUO Ruijuan. Analysis of clinical distribution and drug resistance of 209 Klebsiella pneumoniae strains in a hospital[J]. Guangzhou Medical Journal, 2021, 52(4): 86-91.

参考文献

[1] 周馨,马筱玲,戴媛媛,等.2014-2017年某院肺炎克雷伯菌分布及耐药性分析 [J].中华医院感染学杂志,2019,29(21):3210-3215.
[2] 胡付品,郭燕,朱德妹,等.2017年中国 CHINET 细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251.
[3] 赵峻英,董剑,杨静,等.多重耐药菌的医院感染状况及耐药性分析[J].中国实验诊断学,2018,22(10):1720-1724.
[4] SEPTIMUS E J.Antimicrobial resistance:an antimic robial/diag-nostic stewardship and infection prevention approach[J].Med Clin North Am,2018,102(5):819-829.
[5] 周宏, 时黎明, 李桂霞, 等. 碳青霉烯类抗生素超级耐药细菌检测及抗茵策略研究进展[J].中国病原生物学杂志, 2018, 13(4):432-439.
[6] Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. CLSI supplement M100S[M]. 26th ed. Wayne: PA, 2016: 1.
[7] The European Committee on Antimicrobial Susceptibility Testing(EUCAST). Breakpoint tables for interpretation of MICs and zone diameters [EB/OL]. (2017-10-20)[2018-02-22]. http: /www.Eucast.Ora.
[8] LIB, ZHAO Y, LIU C, et al. Molecular pathogenesis of Klebsiella pneumonia[J]. Future Microbiol, 2014, 9(9):1071-1081.
[9] HU Y F, LIU F, IVAN Y C, et al. Dissemination of the mcr-colistin resistance gene[J]. Lancet Infect Dis, 2015, 16(2):145-146.
[10] YANG R S, FENG Y, LV X Y, et al. Emergence of NDM-5- and MCR-1- Producing Escherichia coli clones ST648 and ST156 from a single muscovy duck (Cairina moschata)[J]. Antimicrob Agents Chemother, 2016, 60(11) : 6899-6902.
[11] 孙洪涛,王延民,魏正军,等. 神经外科患者下呼吸道感染病原菌分布与耐药性分析[J]. 中华医院感染学杂志, 2015, 25(3): 534-536.
[12] 王益丽, 洪春霞, 章学媛, 等. 神经外科患者术后医院感染的临床特点与影响因素及对策分析[J]. 中华医院感染学杂志, 2018, 28(9): 1384-1387.
[13] 陈晓霞,赵滔,曲惠红.耐碳青霉烯肺炎克雷伯菌目标监测预警[J].现代医药卫生,2020,36(2):251-253.
[14] 陈娅,陈鸿,刘瑶,等.耐碳青霉烯类肺炎克雷伯菌医院感染的危险因素分析[J].中华医院感染学杂志,2019,29(8):1131-1135.
[15] OKAMOTO K, LIN M Y, HAVERKATE M, et al. Modifiable risk factors for the spread of Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae among long-term acute-care hospital patients[J]. Infect Control Hosp Epidemiol, 2017, 38(6): 670-677.
[16] 胡付品, 郭燕, 朱德妹, 等.2019 年CHINET三级医院细菌耐药监测[J].中国感染与化疗杂志, 2020,20(3): 233-242.